Breaking News

WuXi STA Opens High Potency Oral Drug Product Manufacturing Facility

New facility expands integrated drug product R&D and manufacturing services to global customers.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi STA, a global contract research development and manufacturing organization (CRDMO), opened its first high potency (HP) oral drug product manufacturing facility at its Wuxi city campus. This new facility marks a milestone for WuXi STA, further extending its drug product capacity and capabilities to meet the growing demand for HP drug candidate development and manufacturing services. With this new facility, WuXi STA is well positioned to provide an integrated R&D and manufacturing netw...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters